OPK - Opko Health Inc logo

OPK

Opko Health Inc

Rev โ€”top 1%20Y
Hold

Opko Health develops and commercializes pharmaceuticals, vaccines, and diagnostics, focusing on serious diseases. It offers laboratory testing services under the BioReference brand, including molecular diagnostics and esoteric tests, in multiple countries.

โš•๏ธ Healthcare NASDAQ Listed 1995 $ USD
$1,000 invested 30 years ago โ†’$390today

Score Overview

1 Year
Score
Net Growth67.69%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-3.12%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.8
Net Growth-141.93%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-66.87%
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Score
Net Growth-50.80%
Net Trend50%
Net Income Consistency
Rev Growth-51.88%
Rev Trend30%
Revenue Consistency
20 Years
Scoreโ€”
Net Growth-110x
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev Trend53%
Revenue Consistency
30 Years
Score
Net Growth-23x
Net Trend47%
Net Income Consistency
Rev Growth5879x
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth-25x
Net Trend45%
Net Income Consistency
Rev Growth5879x
Rev Trend48%
Revenue Consistency

See the full market ranking โ†’

Opko Health Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 1.43B to $ 606M and net income went from $ 30M to -$ 225M. Revenue increased in 0 of those 5 years; net income in 3.

Across Opko Health Inc's full reported history, from 1995 to 2025, revenue grew from $ 100K to $ 606M and net income went from -$ 2M to -$ 225M. Revenue increased in 48% of the years measured; net income in 45%.

Opko Health Inc currently holds a 5-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.39โ€”
1 Year2025-08-12
$ 1.325.30%
5 Years2021-08-12
$ 3.75-62.93%
10 Years2016-08-12
$ 10.06-86.18%
20 Years2006-08-11
$ 0.39256.41%
30 Years1996-08-12
$ 3.56-60.98%
All Time1995-11-02
$ 4.50-69.11%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 587M-$ 72M$ 300M
2025$ 606M-$ 225M$ 369M
2024$ 713M-$ 53M$ 431M
2023$ 863M-$ 188M$ 95M
2022$ 1.00B-$ 328M$ 153M
2021$ 1.77B-$ 30M$ 134M
2020$ 1.43B$ 30M$ 72M
2019$ 901M-$ 314M$ 85M
2018$ 990M-$ 153M$ 96M
2017$ 966M-$ 305M$ 91M
2016$ 1.22B-$ 48M$ 168M
2015$ 491M-$ 30M$ 193M
2014$ 91M-$ 171M$ 96M
2013$ 96M-$ 114M$ 185M
2012$ 47M-$ 29M$ 27M
2011$ 27M-$ 1M$ 71M
2010$ 28M-$ 18M$ 18M
2009$ 13M-$ 30M$ 42M
2008$ 9M-$ 39M$ 6M
2007$ 847K-$ 268M$ 23M
2006-$ 648K$ 8M
2005-$ 186K$ 8M
2004-$ 1M$ 9M
2003$ 13K-$ 5M$ 10M
2002$ 562K-$ 10M$ 16M
2001$ 1M-$ 8M$ 14M
2000$ 865K-$ 7M$ 35M
1999$ 1M-$ 4M$ 3M
1998$ 1M-$ 2M$ 6M
1997$ 100K-$ 3M$ 1M
1996$ 100K-$ 2M$ 2M
IPO1995$ 100K-$ 2M$ 5M

Explore beyond OPK

You're looking at Opko Health Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies